In atopic dermatitis, the first interleukin-22 inhibitor to reach late clinical trials is showing uncommonly broad suppression of biomarkers associated with disease activity.
Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.
A Filipino-led team of international researchers has developed a physics-based algorithm that could train AI to greatly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback